Equity analysts covering Ascelia Pharma are found below:
Danske Bank
Lars Hevreng
+46 8 568 80568
lhev@danskebank.com
Erik Penser Bank
Ludvig Svensson
+46 704 962 535
ludvig.svensson@penser.se
Redeye
Johan Unnerus
+46 724 023 385
johan.unnerus@redeye.se
Analysguiden/Aktiespararna
Sten Westerberg
sten.westerberg@aktiespararna.se
Below you find recent equity research on Ascelia Pharma:
220522 – Analysguiden (in Swedish)
211220 – Erik Penser Bank equity research initiation of coverage (in Swedish)
211111 – Analysguiden (in Swedish)
210520 – Analysguiden (in Swedish)
201023 – Equity Research Redeye (in Swedish)
200526 – Analysguiden (in Swedish)
200325 – Equity Research Redeye (in Swedish)
200305 – Analysguiden-Carlsquare (in Swedish)
200220 – Equity Research Vator Securities
200220 – Analysguiden-Carlsquare (in Swedish)
191014 – Equity Research Redeye (in Swedish)
190619 – Swedish Shareholders Association Equity Research Analysguiden (in Swedish)
190528 – Swedish Shareholders Association Equity Research Analysguiden (in Swedish)